Geneamed on the Fast Track

The end of the year brings some good news.
Geneamed – a company that we have founded together with scientists from the University of Lodz is the winner of the ‘Fast Track’ (Szybka Ścieżka) program.
It will receive over 9 million zlotys for research on using nanoparticles for the treatment of chronic lymphocytic leukemia and other chronic blood diseases
Great news for scientists and the company, but above all for the patients.